Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2000
08/31/2000WO2000050437A1 ANTISENSE MODULATION OF Smad2 EXPRESSION
08/31/2000WO2000050092A1 Antisense modulation of smad1 expression
08/31/2000WO2000050091A1 Antisense modulation of akt-2 expression
08/31/2000WO2000050083A1 Enteral sorbefacients
08/31/2000WO2000050070A2 Preparation for the treatment of pigmentation disorders
08/31/2000WO2000050069A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
08/31/2000WO2000050068A2 Elastin-based compositions
08/31/2000WO2000050067A1 Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1
08/31/2000WO2000050066A1 Treatment of infertility
08/31/2000WO2000050065A1 Treatment of infertility
08/31/2000WO2000050064A2 Synergistic combination for treatment of viral-mediated diseases
08/31/2000WO2000050063A2 Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000050061A1 Detecting the expression of the desc1 gene in squamous cell carcinoma
08/31/2000WO2000050060A1 Therapeutically active mixture of substances containing s-acetylglutathione and aciclovir
08/31/2000WO2000050058A1 Cerebrospinal and vascular pharmaceutical composition and process for preparing the same
08/31/2000WO2000050057A1 Compositions and methods for prevention of photoaging
08/31/2000WO2000050042A1 Methods for the treatment of apolipoprotein e related diseases
08/31/2000WO2000050030A1 New use
08/31/2000WO2000050007A1 Compositions and methods for improved delivery of hydrophobic therapeutic agents
08/31/2000WO2000049991A2 Treatment of trauma
08/31/2000WO2000049937A2 Trpm-2 antisense therapy
08/31/2000WO2000049892A2 Dietetic supplement from human placenta
08/31/2000WO2000049885A1 Milk protein hydrolysate for addressing a bone or dental disorder
08/31/2000WO2000049871A1 An anti-angiogenic kringle protein and its mutants
08/31/2000WO2000032632A3 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use
08/31/2000WO2000028040A3 Cloning of rhadinovirus genome and methods for its use
08/31/2000WO2000028038A3 Virulence genes and proteins, and their use
08/31/2000WO2000028029A3 Cell surface glycoproteins
08/31/2000WO2000028023A3 Ischaemia/reperfusion-inducible dna's and proteins
08/31/2000WO2000027425A3 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders
08/31/2000WO2000027196A8 Use of gm-csf to inhibit development of drug resistance in hiv+ patients
08/31/2000WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000023472A3 Interferon-beta fusion proteins and uses
08/31/2000WO2000023465A3 Methods and reagents for isolating biologically active peptides
08/31/2000WO2000023112A9 Modulation of gene expression by combination therapy
08/31/2000WO2000021548A3 Angiogenically effective unit dose of fgf and method of administering
08/31/2000WO2000020584A9 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
08/31/2000WO2000019823A9 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
08/31/2000WO2000018932A9 Receptor based antagonists and methods of making and using
08/31/2000WO2000018914A3 Novel dkr polypeptides
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000018904A9 Secreted proteins and nucleic acids encoding them
08/31/2000WO2000018795A9 Compositions and methods for wt1 specific immunotherapy
08/31/2000WO2000009657A3 Methods of modulating of angiogenesis
08/31/2000WO1999046368A3 Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment
08/31/2000DE19920704C1 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS The use of an anti-urinary trypsin inhibitor antibody for the diagnosis of the outbreak of AIDS
08/31/2000DE19908766A1 New synthetic peptides from the Vpr protein of human immune deficiency virus, useful e.g. for therapy and diagnosis, have good solubility in water
08/31/2000DE19908423A1 An der Entwicklung des ZNS beteiligtes Protein (TP) The development of the CNS involved protein (TP)
08/31/2000DE19908242A1 Composition for treating pigmentation disorders, e.g. vitiligo, containing the protein DCoH, or related nucleic acids, antibodies or antisera
08/31/2000DE19908041A1 Kovalent verbrückte Insulindimere Covalently bridged insulin dimers
08/31/2000DE10005433A1 Copolymer of lactic and/or glycolic acid, p-dioxanone and polyethylene glycol, which exhibits good depot properties and degradation properties, useful for delivery of e.g. peptides
08/31/2000CA2850318A1 Trpm-2 antisense therapy
08/31/2000CA2371814A1 Trpm-2 antisense therapy
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2366712A1 A means for the prophylactic and therapeutic treatment of streptococcal infections
08/31/2000CA2365094A1 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/31/2000CA2365026A1 Virus vector
08/31/2000CA2365019A1 Novel polypeptide
08/31/2000CA2364780A1 Enteral sorbefacients
08/31/2000CA2363779A1 Human endokine alpha and methods of use
08/31/2000CA2363637A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses
08/31/2000CA2363621A1 A novel inhibitor of programmed cell death
08/31/2000CA2363605A1 Androgen-induced suppressor of cell proliferation and uses thereof
08/31/2000CA2363112A1 Neutrokine-alpha and neutrokine-alpha splice variant
08/31/2000CA2363106A1 Mdm interacting protein and methods of use thereof
08/31/2000CA2363084A1 Therapeutically effective substance mixture
08/31/2000CA2363074A1 Treatment of infertility
08/31/2000CA2363048A1 Treatment of trauma
08/31/2000CA2362940A1 Treatment of infertility
08/31/2000CA2362877A1 Synergistic combination for treatment of viral-mediated diseases
08/31/2000CA2362608A1 Compounds and methods for the detection and prevention of t. cruzi infection
08/31/2000CA2362565A1 Compositions and methods for prevention of photoaging
08/31/2000CA2362549A1 Compositions and methods for modulating serum cholesterol
08/31/2000CA2362548A1 Elastin-based compositions
08/31/2000CA2362520A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
08/31/2000CA2362099A1 T cell receptor v.beta.-d.beta.-j.beta. sequence and methods for its detection
08/31/2000CA2361743A1 Genes associated with diseases of the colon
08/31/2000CA2361396A1 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/31/2000CA2360490A1 Milk protein hydrolysate for addressing a bone or dental disorder
08/30/2000EP1031576A2 Glycopeptide antibiotic derivatives
08/30/2000EP1031575A1 Process for preparing growth hormone secretagogues
08/30/2000EP1031352A2 Use of desmopressin in the preparation of a metastatic dissemination inhibitor medicament during cancer surgery
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1031346A1 Noninvasive vaccination through the skin
08/30/2000EP1030935A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
08/30/2000EP1030920A1 Methods for modulating nerve cell function
08/30/2000EP1030919A2 Cdk2 protein and cdk2 protein complexes
08/30/2000EP1030918A2 Slit polypeptide and method of modulation of robo with ligands
08/30/2000EP1030917A1 Transcriptionally regulated g protein-coupled receptor
08/30/2000EP1030916A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
08/30/2000EP1030915A1 A novel gene and uses therefor
08/30/2000EP1030914A2 Antisense oligonucleotides against tenascin for treating vitiligo
08/30/2000EP1030913A2 Nucleic acid catalysts with endonuclease activity
08/30/2000EP1030911A1 Human aspartic proteases
08/30/2000EP1030910A1 Anti-cocaine catalytic antibody
08/30/2000EP1030868A2 Design of coiled-coil dimer derived antagonists of 4-helix bundle cytokine specific receptors
08/30/2000EP1030867A1 Mammalian milk growth factor
08/30/2000EP1030866A2 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
1 ... 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 ... 3163